-
Mashup Score: 0Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes - 1 year(s) ago
(UPDATED) The FDA required a CV outcomes trial to show the already-approved drug reduced the risk of MACE. The results are in.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Top General Cardiology and Prevention News of 2022 - 1 year(s) ago
The FDA’s fight against Big Tobacco, the return of obicetrapib, and the promise of Lp(a)-lowering all made waves in 2022.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1ACCEL Lite: Top Takeaways from 2022: Preventive Cardiology with Martha Gulati MD - American College of Cardiology - 1 year(s) ago
In this interview, Martha Gulati MD MS FACC FAHA FASPC FESC and Alison L. Bailey MD, FACC, discuss the Top Takeaways from 2022: Preventive Cardiology. Your browser doesn’t support HTML5 audio. Here is a link to the audio instead. Subscribe to the ACCEL Lite Podcast Clinical Topics: Prevention Keywords: ACCELLite < Back to Listings ...
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Bromocriptine appears to drop BP, improve arterial stiffness in teens with type 1 diabetes - 1 year(s) ago
Bromocriptine, a drug previously used to treat adults with type 2 diabetes and Parkinson’s disease, improved BP and central and peripheral aortic stiffness over 4 weeks in adolescents with type 1 diabetes, researchers reported.“We know that abnormalities in the large vessels around the heart, the aorta and its primary branches begin to develop in early childhood in people with type 1
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The ACC’s Prevention of Cardiovascular Disease Member Section and Leadership Council is the home for prevention professionals within the ACC, advocating for and advancing the priorities of the community.
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 23
Some believe using aspirin as a blood thinner is the best preventative of heart disease. However, a recent study explains why that may not be safe.
Source: HealthDigest.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Already Taking a Blood Thinner? Adding Aspirin May Do Harm - 2 year(s) ago
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — For many years, doctors have advised taking low-dose aspirin to help prevent first-time heart attacks and stroke. But increasingly, they’re doing an about-face.The latest warnings come from University of Michigan researchers who reported that patients si…
Source: Consumer Health News | HealthDayCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5
The ACC’s Prevention of Cardiovascular Disease Member Section and Leadership Council is the home for prevention professionals within the ACC, advocating for and advancing the priorities of the community.
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Biggest Study Yet Finds No Link Between Statins, Muscle Aches - 2 year(s) ago
MONDAY, Aug. 29, 2022 (HealthDay News) — Cholesterol-lowering statins are proven lifesavers, but they’ve also gained a reputation for causing muscle aches and pains in a good number of patients.That reputation is undeserved, according to a new large-scale analysis of data from nearly two dozen clin…
Source: Consumer Health News | HealthDayCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
WEDNESDAY, Aug. 24, 2022 (HealthDay News) — People with type 2 diabetes might face a substantially increased risk of heart failure if they take ibuprofen or some other type of nonsteroidal anti-inflammatory drug (NSAID), a new Danish study indicates.Short-term NSAID use increased risk of hospitaliz…
Source: Consumer Health News | HealthDayCategories: Cardiology News and Journals, Latest HeadlinesTweet
The CLEAR Outcomes trial found that treating #statin-intolerant patients w/ bempedoic acid reduced the risk of major adverse CV events. #ACCPrev Chair @DrEugeneYang shared his insights on the study at #ACC23/#WCCardio. Read more in @TCTMD: https://t.co/EO4JpvsuiP @michaelTCTMD